News

Mallinckrodt plc: Mallinckrodt Receives Necessary Ruling from Irish High Court to Combine with Endo, Inc.
Closing of the Merger Expected in Early August DUBLIN, July 17, 2025 /PRNewswire/ -- Mallinckrodt plc today announced that the Irish High Court has given the necessary ruling to enable ...
HealthDay on MSN1d
ENDO: Superior Weight Loss Seen With Tirzepatide and Menopausal Hormone Therapy Use
In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is ...
InvestorsHub on MSN3d
Rani Therapeutics Shares Surge After ENDO 2025 Presentation Announcement
Rani Therapeutics Holdings Inc (NASDAQ:RANI) experienced an 18% jump in its stock price following news that the ...
Amylyx Pharmaceuticals Shares Promising Avexitide Data for Post-Bariatric Hypoglycemia at ENDO 2025, Phase 3 Enrollment Nears Completion
Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best low priced pharma stocks to buy now. On July 13, Amylyx Pharmaceuticals announced new exploratory analyses from its Phase 2 PREVENT and ...
Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025
Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label ...
HealthDay on MSN1d
ENDO: Sweeteners, Genetic Predisposition Independently Linked to Early Puberty
Sweetener consumption and genetic predisposition are independently associated with the risk for central precocious puberty (CPP), according to a study presented at ENDO 2025, the annual meeting of the ...
Aviva Biopharm Inc. Unveils Groundbreaking Pre-Clinical Data on d3-T, a First-in-Class Testosterone Therapy for Women at ENDO 2025
T is a Novel, Non-Aromatizing Androgen, Offering the Benefits of Testosterone Without Converting to Estradiol Addressing a ...
Renal & Urology News1d
ENDO: 1999 to 2020 Saw Significant Uptick in Obesity-Related Cancer Deaths
(HealthDay News) — From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July ...
Science Daily2d
Obesity is driving a hidden cancer epidemic—13 types and rising deaths nationwide
Obesity-related cancer deaths in the U.S. have tripled in just two decades, with women, older adults, and minority groups ...
The Bakersfield Californian3d
Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating ...
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics ...
Mallinckrodt Receives Necessary Ruling from Irish High Court to Combine with Endo, Inc.
Mallinckrodt plc today announced that the Irish High Court has given the necessary ruling to enable its combination with Endo, Inc. (OTCQX: NDOI), advancing the companies' plan to merge in a stock and ...